Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome. De Sio V, Gragnano F, Capolongo A, Guarnaccia N, et al. Int J Cardiol 2025;423:133028.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

De Sio V, Gragnano F, Capolongo A, Guarnaccia N, et al. Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome. Int J Cardiol 2025;423:133028.
PMID: 39890028